Norihiko Saito

Ohashi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Whole-Body Diffusion-Weighted Imaging With Background Body Signal Suppression for Primary Tumor Detection in Patients With Brain Metastases.

Whole-Body Diffusion-Weighted Imaging With Background Body Signal Suppression for Primary Tumor Detection in Patients With Brain Metastases.

Journal: Cureus
Published: November 02, 2025

EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK.

EphrinA2 promotes glioma cell migration and invasion through EphA2 and FAK.

Journal: Cancer cell international
Published: November 30, 2024

Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group.

Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group.

Journal: Japanese journal of clinical oncology
Published: April 27, 2024

Comparative Study of Postmortem MRI and Pathological Findings in Malignant Brain Tumors.

Comparative Study of Postmortem MRI and Pathological Findings in Malignant Brain Tumors.

Journal: Cureus
Published: March 15, 2024

Delayed Pseudoprogression in Glioblastoma Patients Treated With Tumor-Treating Fields.

Delayed Pseudoprogression in Glioblastoma Patients Treated With Tumor-Treating Fields.

Journal: Cureus
Published: February 28, 2024

Evaluation of Treatment Strategies for Male Prolactin-Secreting Pituitary Neuroendocrine Tumors.

Evaluation of Treatment Strategies for Male Prolactin-Secreting Pituitary Neuroendocrine Tumors.

Journal: Cureus
Published: February 19, 2024

Endoscopic Treatment of a Symptomatic Pineal Cyst

Endoscopic Treatment of a Symptomatic Pineal Cyst

Journal: No shinkei geka. Neurological surgery
Published: November 01, 2019

Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model.

Genetic and Lineage Classification of Glioma-Initiating Cells Identifies a Clinically Relevant Glioblastoma Model.

Journal: Cancers
Published: August 25, 2019

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.

Journal: Cancers
Published: December 16, 2018

Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.

Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.

Journal: Oncotarget
Published: July 20, 2016

Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.

Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastoma.

Journal: Brain tumor pathology
Published: October 28, 2014

A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.

A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.

Journal: Stem cells (Dayton, Ohio)
Published: March 05, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026